Security key
45828J103
INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS)
CUSIP: 45828J103
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 2,961,433
- Total 13F value
- $721,188
- Share change
- +982,735
- SEC-reported price per share
- $0.24
- Number of holders
- 26
- Value change
- +$231,320
- Number of buys
- 15
- Number of sells
- 7
- Shares outstanding
- 48,324,727
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
26
Top holders
10
INTS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
INTENSITY THERAPEUTICS, INC. SEC filings
INTENSITY THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45828J103
Recent filing periods:
Ownership snapshot
Top reported holders of INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SAPIENT CAPITAL LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 3.9%
13D/G row: SAPIENT CAPITAL LLC
Showing 1-6 of 15 holder rows.
Quick read
SAPIENT CAPITAL LLC leads the comparable SEC ownership view at 3.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SAPIENT CAPITAL LLC's linked filing trail.
Comparable ownership
Top 5
SAPIENT CAPITAL LLC
3.9%
ARMISTICE CAPITAL, LLC
2.6%
Rothschild Wealth LLC
0.41%
BROWN ADVISORY INC
0.27%
Mesirow Financial Investment Mana...
0.23%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SAPIENT CAPITAL LLC |
13D/G
13F
Company
|
3.9%
|
$312,575
976,797 shares
|
-$11,287 | 30 Jun 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
2.6%
|
$383,505
1,237,113 shares
|
+$113,015 | 30 Jun 2025 |
| Rothschild Wealth LLC |
13F
Company
|
0.41%
|
$61,190
199,316 shares
|
— | 30 Jun 2025 |
| BROWN ADVISORY INC |
13F
Company
|
0.27%
|
$39,932
130,072 shares
|
— | 30 Jun 2025 |
| Mesirow Financial Investment Management, Inc. |
13F
Company
|
0.23%
|
$33,770
110,000 shares
|
— | 30 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.15%
|
$22,355
72,813 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
26
Shares
2,961,433
Rows available
26
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
27
Q3 2025 holders
26
Holder diff
-1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend